Physician

Arnold K.n. Yee, M.D.

According to 2025 Medicare claims, Arnold Yee, M.D. (NPI: 1194792119) practices medical oncology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS OF HAWAII, LLC (NPI: 1629835814; TIN: 991656366) and primary practice location at 96701-9998. Yee is affiliated with the QCIPN (ACO ID: A4614), participating under the MSSP model.

Yee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 667 traditional Medicare patients, billed 90,071 HCPCS/CPT codes, and received $1,803,670 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,664 prescription claims across 458 beneficiaries totaling $6,311,848 in drug costs, led by Xtandi (Enzalutamide). DME data shows 23 claims. Open Payments data shows 141 records totaling $4,361. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $958,015 and ending at $1,803,670. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,079,498 to $6,311,848. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	349	95,325	$958,015
2016	376	130,990	$1,215,889
2017	440	141,044	$852,684
2018	433	86,839	$985,924
2019	439	108,017	$1,063,921
2020	444	86,604	$1,318,969
2021	647	79,021	$1,383,089
2022	675	75,898	$1,179,142
2023	626	23,342	$344,034
2024	667	90,071	$1,803,670

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	1,043	$1,079,498
2016	199	1,162	$1,299,478
2017	223	1,253	$1,754,421
2018	263	1,807	$3,296,048
2019	251	1,732	$2,724,294
2020	242	2,019	$3,822,288
2021	445	2,698	$4,939,207
2022	465	3,032	$5,647,606
2023	460	2,930	$5,787,537
2024	458	2,664	$6,311,848

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	16	$16,155
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	27	$3,809
2020	N/R	55	$2,836
2021	11	11	$1,970
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	11	23	$6,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	416	1,075	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	381	989	$69
80053	Blood test, comprehensive group of blood chemicals	166	524	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	285	1,335	$8
36415	Insertion of needle into vein for collection of blood sample	288	1,298	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	54	1,620	$754,003
Jakafi	Ruxolitinib Phosphate	22	660	$404,523
Ibrance	Palbociclib	24	686	$376,098
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	22	616	$329,126
Imbruvica	Ibrutinib	20	560	$323,626

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	N/R	11	$3,460
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	11	12	$2,756

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	140	$3,371	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$990	Boehringer Ingelheim Espana S.A.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arnold K.n. Yee, M.D.?

Tedicare shows public-source Medicare data for Arnold K.n. Yee, M.D. (NPI 1194792119), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arnold K.n. Yee, M.D. have ACO affiliation data?

Arnold K.n. Yee, M.D. is shown with ACO affiliation data for QCIPN (MSSP, ACO ID A4614).

What billing organization is linked to Arnold K.n. Yee, M.D.?

Arnold K.n. Yee, M.D. is linked to AMERICAN ONCOLOGY PARTNERS OF HAWAII, LLC (billing NPI 1629835814) in the available physician profile data.

Does Arnold K.n. Yee, M.D. have Open Payments data?

Arnold K.n. Yee, M.D. has 141 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.